EDSA
Price
$4.05
Change
-$0.03 (-0.74%)
Updated
Oct 11 closing price
MTNB
Price
$3.18
Change
-$0.03 (-0.93%)
Updated
Oct 11 closing price
24 days until earnings call
Ad is loading...

EDSA vs MTNB

Header iconEDSA vs MTNB Comparison
Open Charts EDSA vs MTNBBanner chart's image
Edesa Biotech
Price$4.05
Change-$0.03 (-0.74%)
Volume$16.95K
CapitalizationN/A
Matinas Biopharma Holdings
Price$3.18
Change-$0.03 (-0.93%)
Volume$12.01K
CapitalizationN/A
View a ticker or compare two or three
EDSA vs MTNB Comparison Chart
Loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
EDSA vs. MTNB commentary
Oct 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a StrongBuy and MTNB is a Hold.

COMPARISON
Comparison
Oct 14, 2024
Stock price -- (EDSA: $4.05 vs. MTNB: $3.18)
Brand notoriety: EDSA and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 171% vs. MTNB: 1%
Market capitalization -- EDSA: $13.93M vs. MTNB: $17.91M
EDSA [@Biotechnology] is valued at $13.93M. MTNB’s [@Biotechnology] market capitalization is $17.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 2 TA indicator(s) are bullish.

  • EDSA’s TA Score: 2 bullish, 7 bearish.

Price Growth

EDSA (@Biotechnology) experienced а -4.98% price change this week, while MTNB (@Biotechnology) price change was +5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

EDSA is expected to report earnings on Dec 13, 2023.

MTNB is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTNB($17.9M) has a higher market cap than EDSA($13.9M). EDSA YTD gains are higher at: -11.429 vs. MTNB (-70.583). EDSA has higher annual earnings (EBITDA): -6.95M vs. MTNB (-22.8M). MTNB has more cash in the bank: 6.22M vs. EDSA (2.04M). EDSA has less debt than MTNB: EDSA (38.8K) vs MTNB (3.24M). EDSA (0) and MTNB (0) have equivalent revenues.
EDSAMTNBEDSA / MTNB
Capitalization13.9M17.9M78%
EBITDA-6.95M-22.8M30%
Gain YTD-11.429-70.58316%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.04M6.22M33%
Total Debt38.8K3.24M1%
FUNDAMENTALS RATINGS
EDSA vs MTNB: Fundamental Ratings
EDSA
MTNB
OUTLOOK RATING
1..100
535
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
7694
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (28) in the Biotechnology industry is significantly better than the same rating for EDSA (98) in the null industry. This means that MTNB’s stock grew significantly faster than EDSA’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EDSA (100) in the null industry. This means that MTNB’s stock grew similarly to EDSA’s over the last 12 months.

MTNB's SMR Rating (98) in the Biotechnology industry is in the same range as EDSA (98) in the null industry. This means that MTNB’s stock grew similarly to EDSA’s over the last 12 months.

EDSA's Price Growth Rating (76) in the null industry is in the same range as MTNB (94) in the Biotechnology industry. This means that EDSA’s stock grew similarly to MTNB’s over the last 12 months.

EDSA's P/E Growth Rating (100) in the null industry is in the same range as MTNB (100) in the Biotechnology industry. This means that EDSA’s stock grew similarly to MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDSA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

EDSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with MTNB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
-0.79%
MTNB - EDSA
52%
Loosely correlated
-0.93%
AKRO - EDSA
40%
Loosely correlated
+1.89%
SNPX - EDSA
33%
Poorly correlated
+0.05%
ORMP - EDSA
32%
Poorly correlated
+0.21%
RNAZ - EDSA
31%
Poorly correlated
-4.03%
More